Voyager Therapeutics Inc
VYGR4.210USD
+0.210+5.25%
Close 12/22, 16:00（ET）Quotes delayed by 15 min
233.58MMarket Cap
LossP/E TTM
Voyager Therapeutics Inc Earnings Date
Period
FY2024 Earnings Date
Revenue(YoY)
80.00M
-68.00%
EPS(YoY)
-1.13
-136.65%
Analyst Rating
STRONG BUY
2025-12-09
Financial Indicators
EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Relevant data have not been disclosed by the company yet.
Income Statement
Revenue
Operating profit
Net Profit
Relevant data have not been disclosed by the company yet.
Balance Sheet
Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Relevant data have not been disclosed by the company yet.
Cash Flow Statement
Net operating income
Net investment
Net financing
Relevant data have not been disclosed by the company yet.
FAQs
What is the total revenue of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its total revenue reached 80.00M, with a year-on-year change of -68.00%.
What is the Earnings Per Share (EPS) of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its Earnings Per Share (EPS) was -1.127, with a year-on-year change of -136.65%.
What is the net income of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its net income was -65.00M, with a year-on-year change of -149.12%.
What is the net margin of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its net profit margin was -81.25%, with a year-on-year change of -253.51%.
What is the gross margin of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its gross margin was 100.00%, with a year-on-year change of --.
What is the debt-to-asset ratio of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its debt-to-asset ratio was --, with a year-on-year change of --.
What is the Return on Equity (ROE) of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its Return on Equity (ROE) was -24.25%, with a year-on-year change of -127.06%.
What is the Return on Assets (ROA) of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its Return on Assets (ROA) was -17.47%, with a year-on-year change of -133.70%.
What is the operating profit of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its operating profit was -80.49M, with a year-on-year change of -165.97%.
What are the current assets of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its current assets were 276.81M, with a year-on-year change of -13.41%.
What are the total assets of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its total assets of Voyager Therapeutics Inc were 393.05M, with a year-on-year change of 11.89%.
What are the total liabilities of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its total liabilities of Voyager Therapeutics Inc were 93.29M, with a year-on-year change of -18.85%.
What is the total equity of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its total equity of Voyager Therapeutics Inc was 299.76M, with a year-on-year change of 26.84%.
What is the net operating income of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its net operating income of Voyager Therapeutics Inc was -65.00M, with a year-on-year change of -149.12%.
What is the net investment of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its net investment of Voyager Therapeutics Inc was -94.86M, with a year-on-year change of 33.03%.
What is the net financing of Voyager Therapeutics Inc?
According to Voyager Therapeutics Inc's FY2024 earnings report, its net financing of Voyager Therapeutics Inc was 114.02M, with a year-on-year change of 238.88%.
